Literature DB >> 29168656

Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?

Monica Cheng1, Greg Durm2, Nasser Hanna2, Lawrence H Einhorn2, Feng-Ming Spring Kong1.   

Abstract

Entities:  

Keywords:  NSCLC; PD-1 immune checkpoint inhibition; non-small-cell lung cancer; radiation therapy; radioimmunotherapy; targeted therapy

Mesh：

Substances：

Year:  2017        PMID： 29168656     DOI： 10.2217/fon-2017-0405

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  3 in total

1.  Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers.

Authors:  Qingzhu Liu; Lei Jiang; Ke Li; Hang Li; Gaochao Lv; Jianguo Lin; Ling Qiu
Journal:  Cancer Immunol Immunother       Date:  2021-01-02       Impact factor: 6.968

2.  Immuno-PET imaging of PD-L1 expression in patient-derived lung cancer xenografts with [68Ga]Ga-NOTA-Nb109.

Authors:  Qingzhu Liu; Xiaodan Wang; Yanling Yang; Chao Wang; Jian Zou; Jianguo Lin; Ling Qiu
Journal:  Quant Imaging Med Surg       Date:  2022-06

3.  Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.

Authors:  Christos Chouaïd; Valentine Grumberg; Alexandre Batisse; Romain Corre; Matteo Giaj Levra; Anne-Françoise Gaudin; Martin Prodel; Joannie Lortet-Tieulent; Jean-Baptiste Assié; Francois-Emery Cotté
Journal:  JCO Clin Cancer Inform       Date:  2022-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.